The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
Open accessAbstract
The ligand for CD40 has been recently identified as a 39-kd protein, gp39, expressed on the surface of activated CD4+ T helper cells (Th). In vitro, soluble CD40 and anti-gp39 have been shown to block the ability of Th to activate B cells, suggesting that gp39-CD40 interactions are important to T cell-dependent B cell activation. Here it is shown that in vivo administration of anti-gp39 dramatically reduced both primary and secondary humoral immune responses to erythrocytes and soluble protein antigens without altering responses to the T-independent type II antigen, trinitrophenyl-Ficoll. Treatment of mice for 4 d with anti-gp39 inhibited the anti-sheep red blood cell (SRBC) response for at least 3 wk and inhibited the expression of all immunoglobulin isotypes in secondary responses to the protein antigen, keyhole limpet hemocyanin. To examine the direct effect of anti-gp39 on Th function, SRBC-immune Th cells from anti-gp39-treated mice were adoptively transferred and shown to be fully capable of providing help. These results suggest that anti-gp39 treatment does not cause Th deletion or anergy. Anti-gp39 may mediate its profound immunosuppressive effects on humoral immunity by blocking gp39-CD40 interactions. Moreover, these studies establish gp39-CD40 as an important receptor-ligand pair for the targeting of therapeutic antibodies to control thymus-dependent humoral responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
Molecular and biological characterization of a murine ligand for CD40
Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R., et al. (1992) · Nature · doi:10.1038/357080a0 · Cited by 1,022
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., et al. (1993) · Science · doi:10.1126/science.7679801 · Cited by 830
Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90668-g · Cited by 814
Self-citationNoelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6550 · Cited by 804
Self-citationImmunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., & Tepper, M. A. (1992) · Science · doi:10.1126/science.1496399 · Cited by 790
Self-citationDefective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
Korthäuer, U., Graf, D., Mages, H. W., Brière, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J., & Kroczek, R. A. (1993) · Nature · doi:10.1038/361539a0 · Cited by 721
CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM
DiSanto, J. P., Bonnefoy, J. Y., Gauchatt, J. F., Fischer, A., & Saint Basile, G. D. (1993) · Nature · doi:10.1038/361541a0 · Cited by 704
Stamenkovic, I., Clark, E. A., & Seed, B. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03521.x · Cited by 515
Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., & Aruffo, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05530.x · Cited by 511
Self-citationJabara, H. H., Fu, S. M., Geha, R. S., & Vercelli, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1861 · Cited by 444
Clark, E. A., & Ledbetter, J. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4494 · Cited by 429
Self-citationWilde, D. B., Marrack, P., Kappler, J., Dialynas, D. P., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2178 · Cited by 365
CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation
Noelle, R. J., Ledbetter, J. A., & Aruffo, A. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90068-i · Cited by 324
Self-citationLane, P., Traunecker, A., Hubele, S., Inui, S., Lanzavecchia, A., & Gray, D. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221016 · Cited by 313
Immunodeficiency with hyper-IgM (HIM).
Notarangelo, L. D., Duse, M., & Ugazio, A. G. (1992) · PubMed · Cited by 308
Plaque Forming Cells: Methodology and Theory
Jerne, N. K., Henry, C., Nordin, A. A., Fuji, H., Koros, A. M. C., & Lefkovits, I. (1974) · Immunological Reviews · doi:10.1111/j.1600-065x.1974.tb01588.x · Cited by 283
Kurt-Jones, E. A., Hamberg, S., Ohara, J., Paul, W. E., & Abbas, A. K. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.6.1774 · Cited by 280
Activation of human B lymphocytes through CD40 and interleukin 4
Vallé, A., Zuber, C. E., Defrance, T., Djossou, O., Riem, M. D., & Banchereau, J. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190818 · Cited by 221
Inaba, K., Witmer, M. D., & Steinman, R. M. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.3.858 · Cited by 176
Protein-Specific Helper T-Lymphocyte Formation Initiated by Dendritic Cells
Inaba, K., & Steinman, R. M. (1985) · Science · doi:10.1126/science.3160115 · Cited by 175
Cognate interactions between helper T cells and B cells
Noelle, R. J., & Charles Snow, E. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90142-v · Cited by 168
Self-citationMonoclonal mouse antibodies raised against human lung carcinoma
Hellstrom, I., Horn, D., Linsley, P. S., Brown, J., Brankovan, V., & Hellström, K. E. (1987) · Lung Cancer · doi:10.1016/s0169-5002(87)80426-9 · Cited by 129
Identification of a source of biologically active CD40 ligand
Armitage, R. J., Sato, T. A., Macduff, B. M., Clifford, K. N., Alpert, A., Smith, C. A., & Fanslow, W. C. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220817 · Cited by 80
Thymus‐Dependent Antigenic Stimulation of Hapten‐Specific B Lymphocytes
Snow, E. C., & Noelle, R. J. (1987) · Immunological Reviews · doi:10.1111/j.1600-065x.1987.tb01177.x · Cited by 20
Self-citation
Cited by
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Elgueta, R., Benson, M. J., De Vries, V. C., Wasiuk, A., Guo, Y., & Noelle, R. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00782.x · Cited by 1,625
Self-citationCD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
Activation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
The CD40 Antigen and Its Ligand
Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J., van Kooten, C., Liu, Y. J., Rousset, F., & Saeland, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.881 · Cited by 1,263
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108
Metadata
- Authors
- Foy, T. M., Shepherd, D. M., Durie, F. H., Aruffo, A., Ledbetter, J. A., & Noelle, R. J.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-11-01
- Volume
- 178
- Issue
- 5
- Pages
- 1567-1575
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2008236686
- Cited by
- 348
- References
- 25
- FWCI
- 13.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.